Recent research indicates that Retatrutide, specifically the 40mg dosage , could represent a significant breakthrough in the treatment of excess weight . Distinct from many existing therapies, Retatrutide operates as a double GIP and GLP-1 receptor agonist, potentially causing greater weight loss a